16.77BMarket Cap
24.90P/E TTM
Neurocrine Biosciences Inc
NBIX Balance Sheet
You can check out the annual or quarterly balance sheets of Neurocrine Biosciences Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing NBIX stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does Neurocrine Biosciences Inc Have?
In its most recent quarterly, Neurocrine Biosciences Inc had 332.40M in cash and cash equivalents.
How Much Are Neurocrine Biosciences Inc's Total Liabilities?
Neurocrine Biosciences Inc reported 1.38B in total liabilities as of the latest reported quarter, including 743.40M in current liabilities and 635.00M in non-current liabilities.
What Are Neurocrine Biosciences Inc's Total Assets?
As of the latest reported quarter, Neurocrine Biosciences Inc's total assets were 4.63B, consisting of 2.52B in current assets and 2.11B in non-current assets.
How Much Shareholders' Equity Does Neurocrine Biosciences Inc Have?
Neurocrine Biosciences Inc reported 3.25B in total shareholders' equity as of the latest reported quarter.